Royce Bedward
General Counsel bij ALCON INC.
Profiel
Royce R.
Bedward is currently working as the Secretary, Senior Vice President & General Counsel at Alcon AG since 2016 and as the General Counsel at Aerie Pharmaceuticals, Inc. since 2022.
Previously, he worked at Hospira, Inc. as the Secretary, Senior Vice President & General Counsel from 2004 to 2015.
Mr. Bedward completed his undergraduate degree at St. Norbert College, Inc. and his graduate degree at the University of Illinois College of Law.
Actieve functies van Royce Bedward
| Bedrijven | Functie | Begin |
|---|---|---|
| ALCON INC. | General Counsel | - |
| AERIE PHARMACEUTICALS, INC. | General Counsel | 21-11-2022 |
Eerdere bekende functies van Royce Bedward
| Bedrijven | Functie | Einde |
|---|---|---|
| HOSPIRA, INC. | General Counsel | 01-09-2015 |
Opleiding van Royce Bedward
| St. Norbert College, Inc. | Undergraduate Degree |
| University of Illinois College of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALCON INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
